文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

美国外科医师学会创伤委员会认证等级影响骨盆环损伤的创伤中心管理与患者死亡率

American College of Surgeons Committee on Trauma verification level affects trauma center management of pelvic ring injuries and patient mortality.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论在部分稳定或不稳定骨盆环损伤成人中,入院于一级创伤中心与死亡率降低相关(7.7% vs 11.6%,p=0.02)。

该研究分析2011—2017年29个美国外科医师学会创伤委员会认证的一级和二级创伤中心数据,纳入年龄≥16岁、损伤严重度评分≥5、钝性损伤且存在部分稳定或不稳定骨盆环骨折(AIS 2005版含2008更新编码)的成人,排除直接收治、转出 definitive care、穿透伤及无生命体征者。采用倾向评分匹配形成一级和二级创伤中心各610例的1:1队列。一级创伤中心患者死亡率显著降低(7.7% vs 11.6%,p=0.02);二级创伤中心患者接受介入血管造影、复杂 definitive 骨科手术及入住ICU的比例更低。结论认为部分稳定或不稳定骨盆环损伤收治于一级创伤中心与死亡率降低相关,二级创伤中心对高级治疗方式的使用显著更少。

要点

  • 部分稳定或不稳定骨盆环损伤成人收治于一级创伤中心死亡率7.7%,二级创伤中心11.6%,p=0.02。
  • 二级创伤中心患者接受介入血管造影、复杂 definitive 骨科手术及入住ICU的比例显著更低。
  • 倾向评分匹配后一级和二级创伤中心各610例,基线特征无显著差异。
  • 纳入标准为年龄≥16岁、损伤严重度评分≥5、钝性损伤、部分稳定或不稳定骨盆环骨折。
  • 排除直接收治、转出 definitive care、穿透伤及无生命体征者。

适用人群与场景

  • 成人患者(年龄≥16岁),损伤严重度评分≥5,钝性损伤,且存在部分稳定或不稳定骨盆环骨折(按AIS 2005版含2008更新编码分类)。
  • 排除直接收治、转出以行 definitive care、穿透伤及无生命体征者。
  • 场景为美国外科医师学会创伤委员会认证的一级和二级创伤中心。

诊断标准与关键阈值

  • 骨盆环损伤编码采用简明损伤定级标准(AIS)2005版含2008更新,纳入部分稳定或不稳定骨盆环骨折。

研究设计与关键结果

  • 研究类型为创伤质量协作数据分析(2011—2017年),来自29个美国外科医师学会创伤委员会认证的一级和二级创伤中心。
  • 从1768例总患者中经倾向评分匹配选出1220例匹配良好的患者(一级610例,二级610例),基线特征无显著差异。
  • 一级创伤中心患者死亡率显著降低(7.7% vs 11.6%,p=0.02)。
  • 二级创伤中心患者接受介入血管造影、复杂 definitive 骨科手术及入住ICU的可能性更低。

证据类型、等级与局限

  • 证据类型为经济/决策分析,证据等级为Level II。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,部分稳定或不稳定骨盆环损伤收治于一级创伤中心与死亡率降低相关,二级创伤中心对高级治疗方式的使用显著更少,这一临床实践差异提示可强调适当治疗这些危重患者的潜在流程。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Pelvic ring fractures represent a complex injury that requires specific resources and clinical expertise for optimal trauma patient management. We examined the impact of treatment variability for this type of injury at Level I and II trauma centers on patient outcomes.

METHODS: Trauma quality collaborative data (2011-2017) were analyzed. This includes data from 29 American College of Surgeons Committee on Trauma verified Level I and Level II trauma centers. Inclusion criteria were adult patients (≥16 years), Injury Severity Score of 5 or higher, blunt injury, and evidence of a partially stable or unstable pelvic ring fracture injury coding as classified using Abbreviated Injury Scale version 2005, with 2008 updates. Patients directly admitted, transferred out for definitive care, with penetrating trauma, or with no signs of life were excluded. Propensity score matching was used to create 1:1 matched cohorts of patients treated at Levels I or II trauma centers. Trauma center verification level was the exposure variable used to compare management strategies, resource utilization, and in-hospital mortality in univariate analysis.

RESULTS: We selected 1,220 well-matched patients, from 1,768 total patients, using propensity score methods (610 Level I and 610 Level II cohort). There were no significant baseline characteristic differences noted between the groups. Patients with pelvic ring fractures treated at Level I trauma centers had significantly decreased mortality (7.7% vs. 11.6%, p = 0.02). Patients treated at Level II trauma centers were less likely to receive interventional angiography, undergo complicated definitive orthopedic operative treatment, and to be admitted to an intensive care unit.

CONCLUSION: Admission with a partially stable or unstable pelvic ring injury to a Level I trauma center is associated with decreased mortality. Level II trauma centers had significantly less utilization of advanced treatment modalities. This variation in clinical practice highlights potential processes to emphasize in the appropriate treatment of these critically ill patients.

LEVEL OF EVIDENCE: Economic/Decision, Level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Oliphant BW, Tignanelli CJ, Napolitano LM, et al. American College of Surgeons Committee on Trauma verification level affects trauma center management of pelvic ring injuries and patient mortality. J Trauma Acute Care Surg. 2019. PMID: 30188423. doi:10.1097/TA.0000000000002062

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。